The effects of probiotic supplementation on patients with relapsing-remitting multiple sclerosis: secondary analysis of a randomized double-blind placebo-controlled trial

The effects of probiotic supplementation on patients with relapsing-remitting multiple sclerosis: secondary analysis of a randomized double-blind placebo-controlled trial


چاپ صفحه
پژوهان
صفحه نخست سامانه
نویسندگان
نویسندگان
اطلاعات تفضیلی
اطلاعات تفضیلی
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: امیررضا ناصری , سروین سنایی اسکویی , سما رهنمایان , رضا مصدقی , ملیحه طالبی , مهناز طالبی

عنوان کنگره / همایش: Tenth MENACTRIMS Congress , United Arab Emirates , Dubai , 2025

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله امیررضا ناصری
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه کمیته تحقیقات دانشجویی
کد مقاله 89350
عنوان فارسی مقاله The effects of probiotic supplementation on patients with relapsing-remitting multiple sclerosis: secondary analysis of a randomized double-blind placebo-controlled trial
عنوان لاتین مقاله The effects of probiotic supplementation on patients with relapsing-remitting multiple sclerosis: secondary analysis of a randomized double-blind placebo-controlled trial
نوع ارائه پوستر
عنوان کنگره / همایش Tenth MENACTRIMS Congress
نوع کنگره / همایش بین المللی
کشور محل برگزاری کنگره/ همایش United Arab Emirates
شهر محل برگزاری کنگره/ همایش Dubai
سال انتشار/ ارائه شمسی 1404
سال انتشار/ارائه میلادی 2025
تاریخ شمسی شروع و خاتمه کنگره/همایش 1404/09/14 الی 1404/09/15
آدرس لینک مقاله/ همایش در شبکه اینترنت
آدرس علمی (Affiliation) نویسنده متقاضی Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
امیررضا ناصریاول
سروین سنایی اسکوییدوم
سما رهنمایانسوم
رضا مصدقیچهارم
ملیحه طالبیپنجم
مهناز طالبیششم

اطلاعات تفضیلی
hide/show

عنوان متن
کلمات کلیدیProbiotics; Multiple Sclerosis; Information Process Speed; Cognitive Function; Randomized Controlled Trial
خلاصه مقالهINTRODUCTION Probiotics, via the gut-brain axis, are suggested to be associated with improved symptoms in Multiple sclerosis (MS). AIM This study investigates the effects of probiotic supplementation on depressive symptoms, cognitive outcomes and hand function in relapsing-remitting MS (RRMS) patients. METHODS In this parallel, randomized, double-blind, placebo-controlled trial, 90 RRMS patients, with Expanded Disability Status Scale (EDSS)<4, received either the probiotic (Lactocare®) or a placebo twice daily for four months. Blinding was performed for outcome assessors and the patients. Patients with a prior clinical diagnosis of depression were excluded from the sample and depressive symptoms were assessed using the Beck Depression Inventory-II (BDI-II). Visual information process speed (IPS) was evaluated using the Symbol Digit Modalities Test (SDMT), and the three-second version of the Paced Auditory Serial Addition Test (PASAT-3) was used to assess auditory IPS. Manual dexterity was assessing using the Nine-Hole Peg Test (9HPT). With adjustments based on before values, the ANCOVA test was utilized to estimate the data, using the 23rd version of SPSS software. RESULTS Out of 90 randomized patients, 60 completed the trial (29 in the probiotics group, 31 in the placebo group). Estimated values for BDI-FS (p-value: 0.13), SDMT (p-value: 0.68), PASAT (p-value: 0.53), 9HPT-R (p-value: 0.80), 9HPT-L (p-value: 0.10), 9HPT-A (p-value: 0.65), and 9HPT-M (p-value: 0.30) did not differ significantly between the groups of the study. CONCLUSIONS Supplementation with a seven-strain probiotics product for four months does not result in a significant improvement in cognitive outcomes, depressive symptoms, and manual dexterity in RRMS patients with EDSS<4.

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
PB.pdf1404/10/1710822208دانلود
P1008.pdf1404/09/27214599دانلود